<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02605408</url>
  </required_header>
  <id_info>
    <org_study_id>CTI742-P001</org_study_id>
    <nct_id>NCT02605408</nct_id>
  </id_info>
  <brief_title>Cataract Surgery in Indian Patients With or Without LenSx® Laser</brief_title>
  <official_title>A Phaco ± LenSx® Procedure Patients Registry in Indian Tertiary Medical Centers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to record and analyze the profile and outcome of cataract
      patients receiving phacoemulsification (phaco) and artificial intraocular lens (IOL)
      implantation with or without femtosecond laser-assisted cataract surgery (FLACS) in Indian
      tertiary medical centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Legitimate patients will receive Standard of Care (SOC) phacoemulsification treatment for
      cataract and IOL implantation, with or without using LenSx® technology, with followup for 1
      month using SOC postsurgical treatment.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Management Decision
  </why_stopped>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Completion rate of an anterior capsulotomy</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>Up to Day 30 postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Uncorrected Visual Acuity (UCVA)</measure>
    <time_frame>Up to Day 30 postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative dissipated energy (CDE)</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>Cumulative Dissipated Energy (the amount of ultrasound energy entering the eye during the removal of the cataractous lens) will be reported on the Vision System interface and measured in percent-seconds.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total phaco + IOL time</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Aspiration fluid (ml)</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Success rate of IOL insertion</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion rate of cornea incision</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Laser procedure time from suction on to off</measure>
    <time_frame>Day 0, operative day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Cataracts</condition>
  <arm_group>
    <arm_group_label>Cataract surgery</arm_group_label>
    <description>Phacoemulsification and artificial IOL implantation with and without LenSx® laser system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LenSx® laser system</intervention_name>
    <description>Femtosecond laser system used for cornea incision, capsulotomy and lens fragmentation during cataract surgery</description>
    <arm_group_label>Cataract surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification</intervention_name>
    <description>Removal of the cataractous lens</description>
    <arm_group_label>Cataract surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with cataracts who are receiving phacoemulsification (with or without LenSx®
        procedure) consecutively during the registry period
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Agree to undergo phacoemulsification cataract surgery in at least 1 eye;

          -  Understand and sign an informed consent form;

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Refuse to sign the informed consent form or have incomplete medical records;

          -  Contraindications for phacoemulsification treatment per Investigator discretion or
             listed in LenSx® Operator's Manual;

          -  Contraindications for anterior capsulotomy, phacofragmentation of the lens using the
             FLACS;

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Head Medical Affairs, MD</last_name>
    <role>Study Director</role>
    <affiliation>Alcon India Pvt. Ltd.</affiliation>
  </overall_official>
  <removed_countries>
    <country>India</country>
  </removed_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2015</study_first_submitted>
  <study_first_submitted_qc>November 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2015</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

